Moreover, we found that the levels of both PTEN and p16 in CD34+/CD38−/CD82+ AML cells were lower than they were in CD34+/CD38−/CD82− AML cells (Fig 4D). The gene discussed is CDKN2A; the disease is acute myeloid leukemia.